Knee Injuries, Sport InjurySport _MWM_RTCNCT07510243
Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players
A study testing Mulligan Mobilization with movement MWM and Kinesiotaping in people with Knee Injuries, Sport Injury and Knee Injuries, run by University Aleksander Moisiu Durres at 1 site in Albania.
Trial summary
This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. Read more about this study
- Who is it for?
- Ages 14 to 22 years
- Conditions the study is for
- Knee Injuries, Sport Injury, Knee Injuries
- What is being tested?
- Mulligan Mobilization with movement MWM and Kinesiotaping
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 60 participants
- Where
- 1 siteAlbania
- Study dates
- 6 Jan 2025to 27 Feb 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 22 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Male and female basketball players Minimum of 2 years of sports experience Presence of knee injury Active participation in organized sports
Who cannot join
- Previous knee surgery Knee instability Neurological disorders Refusal or contraindication to Mulligan mobilization
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players: A Parallel -Group Randomized Controlled Trial
This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. In this study, 3 forms of intervention were used: Mulligan, Kinesiotaping and placebo in young basketball players with knee injuries.
Read the detailed description
Study type: Randomized Clinical Trial RTC ,with three intervention groups. Population: young basketball players. The intervention will last 2 weeks. Outcomes: KOS-ADLS; OSTRC. Statistical analysis: Mixed ANOVA
- Conditions
- Knee Injuries, Sport Injury, Knee Injuries
- Being tested
- Mulligan Mobilization with movement MWM, Kinesiotaping, Placebo
- Keywords
- Mulligan technique, kinesiotaping, Sports physiotherapy, randomized controlled trial, Mulligan technique, Kinesiotaping, Sports physiotherapy, randomized controlled, basketball players, sports injury
- Medical subject headings
- Knee Injuries, Athletic Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mulligan Mobilization with movement MWMOther
Participants received the MWM technique in a squat position with a tibial glide by a physiotherapist certified in the mulligan concept twice a week for 2 weeks, the treatment lasted 5 minutes.
KinesiotapingOther
Participants received the same kinesiotaping pattern regardless of injury type twice a week for 2 weeks for 5 minutes.
PlaceboOther
Participants received a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks, lasting 5 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Mulligan Mobilization with movement MWM | Experimental | Participants received MWM in the squot position with tibial glide by a physiotherapist licensed to apply the Mulligan technique. 2 times a week for 2 weeks with a duration of 5min. Receives: Other: Mulligan Mobilization with movement MWM |
| Kinesiotaping | Active comparator | Participants in the kinesiotaping group were applied the same kinesiotaping pattern regardless of injury type, with a frequency of 2 times a week for 2 weeks. Receives: Other: Kinesiotaping |
| Placebo | Placebo comparator | Placebo participants underwent a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks for 5 minutes. Receives: Other: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
KOS-SAS (ADLS)
The Activities of Daily Living Scale (ADLS) subscale of the Knee Outcome Survey evaluates symptoms and functional limitations during daily activities. Scores range from 0 to 100, with higher scores indicating better function.
Measured: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
Secondary outcomes (1)
Overuse Injury Questionnaire - Oslo Sports Trauma Research Center (OSTRC)
The Oslo Sports Trauma Research Center (OSTRC) Overuse Injury Questionnaire is a validated self-report instrument used to monitor the severity and impact of overuse-related musculoskeletal problems. It evaluates the consequences of knee-related problems on sports participation, training volume, sports performance, and symptom severity. Responses to the four key questions are converted into a severity score ranging from 0 to 100, where higher scores indicate greater symptom severity and functional impairment.
Measured: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2026
- Study start6 Jan 2025
- Primary completion27 Jun 2025
- Study completion27 Feb 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Knee Injuries, Sport InjuryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants are randomly assigned to one of three groups (mulligan, kinesiotaping and placebo.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Aleksander Moisiu Durres
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Selda Sokoli Veizaj, University Aleksander Moisiu Durres
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07510243
- Sponsor's protocol ID
- Sport_MWM_RTC_"2026
- Other IDs
- Sport_MWM_RTC
- Acronym
- Sport _MWM_RTC
- Status last verified
- Mar 2026
- First submitted
- 11 Mar 2026
- Last updated
- 3 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The individual participant data (IPD) from this study will not be shared due to ethical and privacy considerations. The study involves minor athletes (under 18 years old), and participant consent does not include data sharing with external researchers. To ensure confidentiality and comply with ethical approvals, the data will remain restricted to the study investigators.
Publications
https://www.consort-statement.org
https://doi.org/10.1093/ptj/78.2.115
https://doi.org/10.1136/bjsports-2012-091524